Akari Therapeutics Announces Reverse Stock Split and ADS Ratio Adjustment

Akari Therapeutics, Plc (NASDAQ:AKTX) is a biotechnology company that focuses on developing treatments for oncology. The company is preparing for a significant change in its stock structure. On March 31, 2026, AKTX will implement a reverse stock split, exchanging 1 share for every 40 shares. This move is part of a broader strategy to maintain compliance with Nasdaq's listing requirements.In addition to the reverse stock split, Akari is adjusting the ratio of its American Depositary Shares (ADSs) to ordinary ...